ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1111

$633K Total Retail Price of All Prescriptions

Rank: 131 out of 1111

429 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

43% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

5% of this provider’s 5,165 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 768 328 S3 1 1
OXYCODONE HCL-ACETAMINOPHEN 408 72 S2 2 86
LISINOPRIL 339 199 3 2
OMEPRAZOLE 257 140 4 4
LEVOTHYROXINE SODIUM 235 172 5 3
GABAPENTIN 233 82 6 10
CARISOPRODOL 225 21 R 7 54
ZOLPIDEM TARTRATE 197 127 8 16
SIMVASTATIN 189 101 9 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 83 10 23
MORPHINE SULFATE ER 174 48 S2 11 74
NEXIUM 173 88 12 26
FUROSEMIDE 166 114 13 6
METFORMIN HCL 153 106 14 8
AMLODIPINE BESYLATE 140 102 15 7
CYCLOBENZAPRINE HCL 130 37 R 16 37
PROAIR HFA 129 47 17 38
POTASSIUM CHLORIDE 126 90 18 9
MELOXICAM 121 58 19 18
MORPHINE SULFATE 114 29 S2 20 190
ROPINIROLE HCL 113 64 21 68
TRAMADOL HCL 107 55 22 13
OXYCONTIN 106 21 S2 23 106
PAROXETINE HCL 101 61 24 55
TAMSULOSIN HCL 100 73 25 28
CYMBALTA 96 32 26 40
PROMETHAZINE HCL 94 46 R 27 69
ATORVASTATIN CALCIUM 93 80 28 15
HYDROCHLOROTHIAZIDE 91 54 29 11
SERTRALINE HCL 90 52 30 24
RANITIDINE HCL 84 46 31 29
ENDOCET 83 23 S2 32 134
ATENOLOL 82 67 33 22
TIZANIDINE HCL 79 15 34 91
CITALOPRAM HBR 78 29 35 14
ALLOPURINOL 77 68 36 36
PREMARIN 74 54 R 37 90
CARVEDILOL 70 34 38 21
LYRICA 68 27 39 62
CRESTOR 67 42 40 33
OXYCODONE HCL 61 0 S2 41 69
TRAZODONE HCL 58 21 42 32
SYMBICORT 56 18 43 176
ADVAIR DISKUS 56 42 43 43
ISOSORBIDE MONONITRATE ER 56 46 43 73
FENTANYL 56 23 S2 43 65
IBUPROFEN 53 16 47 66
METOPROLOL SUCCINATE 52 30 48 20
FLUTICASONE PROPIONATE 51 33 49 27
CLOPIDOGREL 51 34 49 30
SPIRIVA 51 41 49 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.